SCHEMBL1769931

SCHEMBL1769931

O=C(CS(=O)(=O)Cc1ccccn1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.55
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
P2RX7 Q99572 2/20 0.50
RAB9A P51151 2/20 0.48
MAPT P10636 1/20 0.48
AGTR1 P30556 1/20 0.48
OPRK1 P41145 1/20 0.48
RECQL P46063 1/20 0.48
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GRM5 P41594 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
EPHX2 P34913 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770013 0.78 HSD11B1 (0.50) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL1770044 0.78 CYP19A1 (0.53) HSD11B1ALDH1A1P2RX7SMN1; SMN2HTT
SCHEMBL1770138 0.76 ALDH1A1 (0.56) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL1770111 0.76 RAB9A (0.54) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL3321013 0.76 HSD11B1 (0.60) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL5327570 0.76 P2RX7 (0.46) HSD11B1ALDH1A1KDM4EP2RX7MAPT
SCHEMBL1769963 0.75 HSD11B1 (0.62) HSD11B1ALDH1A1P2RX7SMN1; SMN2TSHR
SCHEMBL1770121 0.74 ALDH1A1 (0.43) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL1769922 0.74 HSD11B1 (0.53) HSD11B1ALDH1A1KDM4EP2RX7RAB9A
SCHEMBL13333014 0.73 HSD11B1 (0.76) HSD11B1ALDH1A1KDM4EP2RX7RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885ALDH1A1 307/4885KDM4E 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.